cp 122288 has been researched along with naratriptan in 1 studies
Studies (cp 122288) | Trials (cp 122288) | Recent Studies (post-2010) (cp 122288) | Studies (naratriptan) | Trials (naratriptan) | Recent Studies (post-2010) (naratriptan) |
---|---|---|---|---|---|
17 | 1 | 0 | 205 | 24 | 48 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beleta, J; Doménech, T; Palacios, JM | 1 |
1 other study(ies) available for cp 122288 and naratriptan
Article | Year |
---|---|
Characterization of human serotonin 1D and 1B receptors using [3H]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist.
Topics: Benzamides; Binding, Competitive; Gene Expression; HeLa Cells; Humans; Kinetics; Ligands; Pyridines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Substantia Nigra; Tritium | 1997 |